187 related articles for article (PubMed ID: 32663531)
1. Immunization of turkeys with a DNA vaccine expressing the haemagglutinin gene of low pathogenic avian influenza virus subtype H9N2.
Shehata AA; Basiouni S; Ali A; Fawzy M; Hafez HM; Ulbert S; Vahlenkamp T
J Virol Methods; 2020 Oct; 284():113938. PubMed ID: 32663531
[TBL] [Abstract][Full Text] [Related]
2. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
3. H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals.
Lee DH; Park JK; Lee YN; Song JM; Kang SM; Lee JB; Park SY; Choi IS; Song CS
Vaccine; 2011 May; 29(23):4003-7. PubMed ID: 21463681
[TBL] [Abstract][Full Text] [Related]
4. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus.
Pan Z; Zhang X; Geng S; Cheng N; Sun L; Liu B; Huang J; Jiao X
Vaccine; 2009 Feb; 27(7):1018-23. PubMed ID: 19103246
[TBL] [Abstract][Full Text] [Related]
5. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
[TBL] [Abstract][Full Text] [Related]
6. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.
Nagy A; Lee J; Mena I; Henningson J; Li Y; Ma J; Duff M; Li Y; Lang Y; Yang J; Abdallah F; Richt J; Ali A; García-Sastre A; Ma W
Vaccine; 2016 May; 34(23):2537-45. PubMed ID: 27102817
[TBL] [Abstract][Full Text] [Related]
8. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
9. Vaccine Protection of Turkeys Against H5N1 Highly Pathogenic Avian Influenza Virus with a Recombinant Turkey Herpesvirus Expressing the Hemagglutinin Gene of Avian Influenza.
Kapczynski DR; Dorsey K; Chrzastek K; Moraes M; Jackwood M; Hilt D; Gardin Y
Avian Dis; 2016 Jun; 60(2):413-7. PubMed ID: 27309280
[TBL] [Abstract][Full Text] [Related]
10. Construction of a recombinant duck enteritis virus vaccine expressing hemagglutinin of H9N2 avian influenza virus and evaluation of its efficacy in ducks.
Sun Y; Yang C; Li J; Li L; Cao M; Li Q; Li H
Arch Virol; 2017 Jan; 162(1):171-179. PubMed ID: 27709401
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.
Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM
Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397
[TBL] [Abstract][Full Text] [Related]
12. Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
Li X; Ju H; Liu J; Yang D; Qi X; Yang X; Qiu Y; Zheng J; Ge F; Zhou J
Influenza Other Respir Viruses; 2017 Nov; 11(6):518-524. PubMed ID: 28752641
[TBL] [Abstract][Full Text] [Related]
13. Recombinant turkey herpesvirus expressing H9 hemagglutinin providing protection against H9N2 avian influenza.
Liu L; Wang T; Wang M; Tong Q; Sun Y; Pu J; Sun H; Liu J
Virology; 2019 Mar; 529():7-15. PubMed ID: 30641481
[TBL] [Abstract][Full Text] [Related]
14. Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.
Ducatez MF; Becker J; Freudenstein A; Delverdier M; Delpont M; Sutter G; Guérin JL; Volz A
Vet Microbiol; 2016 Jun; 189():59-67. PubMed ID: 27259828
[TBL] [Abstract][Full Text] [Related]
15. Protective Efficacy of Inactivated H9N2 Vaccine in Turkey Poults under Both Experimental and Field Conditions.
Elfeil WK; Youssef H; Sedeek A; El-Shemy A; Abd-Allah EM; Elkady MF; El Sayed EK; Bazid AI; Abdallah MS
Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560588
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Avian Influenza Virus Subtype H9N2 in Turkeys and Evaluation of Inactivated Vaccine Efficacy.
Fellahi S; Nassik S; Maaroufi I; Tligui NS; Touzani CD; Rawi T; Delvecchio A; Ducatez MF; Houadfi ME
Avian Dis; 2021 Mar; 65(1):46-51. PubMed ID: 34339121
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Two Oil Adjuvant-Inactivated Avian Influenza H9N2 Vaccines.
Kilany WH; Bazid AH; Ali A; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):226-31. PubMed ID: 27309059
[TBL] [Abstract][Full Text] [Related]
18. Generation and Evaluation of Recombinant Thermostable Newcastle Disease Virus Expressing the HA of H9N2 Avian Influenza Virus.
Zhang X; Bo Z; Meng C; Chen Y; Zhang C; Cao Y; Wu Y
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452473
[TBL] [Abstract][Full Text] [Related]
19. Antigenic Cartography of H9 Avian Influenza Virus and Its Application to Vaccine Selection.
Wang Y; Davidson I; Fouchier R; Spackman E
Avian Dis; 2016 May; 60(1 Suppl):218-25. PubMed ID: 27309058
[TBL] [Abstract][Full Text] [Related]
20. Immunoprotection against influenza virus H9N2 by the oral administration of recombinant Lactobacillus plantarumNC8 expressing hemagglutinin in BALB/c mice.
Shi SH; Yang WT; Yang GL; Cong YL; Huang HB; Wang Q; Cai RP; Ye LP; Hu JT; Zhou JY; Wang CF; Li Y
Virology; 2014 Sep; 464-465():166-176. PubMed ID: 25083619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
